Patients could receive upto Rs 15 lakh aid under govt’s proposed rare diseases policy
The health ministry had formulated the policy in July 2017 and proposed providing the financial aid for one-time treatment of patients with rare diseases.
PM Modi warns pharma companies not to bribe doctors with women, foreign trips and gadgets
Modi met senior officials from top drug-makers like Zydus Cadila, Torrent & Wockhardt, and said their non-compliance is forcing govt to create a strict law.
Your body clock affects your immune system. Removing the clock gene helps fight bacteria
We now live with cheap, bright, artificial light, shift-work, sleep-deprivation – all major challenges to the ancient control mechanisms in our bodies.
Modi govt plans action against US writer who said Indian drugs are ‘flea-market quality’
In her May 2019 book Bottle of Lies, Katherine Eban accused Indian pharma firms of major lapses such as ‘toxic impurities’ and fudging data on quality control.
Chyawanprash, amla, herbal tea will be checked to verify health benefit claims
Modi govt will soon roll out regulations to check ayurvedic food products whose market is unregulated. A final notification is likely to be issued by February.
Male kids & adolescents who self-harm more likely to commit suicide later, says Lancet study
Lancet study, conducted in England, focused on individuals aged 10–18 years who went to hospitals after they caused non-fatal self-harm between 1 January 2000 & 31 December 2013.
India could soon find all its ‘missing million’ TB patients — highest-ever detection in 2019
In 2019, the detection of TB cases in India reached its highest ever at 23.5 lakh patients, against an estimated 26.9 lakh cases.
Study finds baby powder not likely a risk for ovarian cancer
The US-govt-sponsored study may help Johnson & Johnson's fight against 17,000 lawsuits contending that talc-based personal hygiene products cause ovarian cancer in women.
Drug to treat epilepsy, bipolar disorder must carry warning about ‘immune system reaction’
Lamotrigine is sold in India under more than 20 brand names, including Lamitor, Lametec, Lamosyn and Lamez.
At Kota hospital, 100 deaths in a month not a first — 1,100 kids died every year since 2014
Families accuse doctors of negligence, but Kota's JK Lon Hospital blames the large number of referral cases it gets — "all patients reached us in a very critical situation".
As Modi govt doubles down on CAA, long-time friend Bangladesh moves closer to China
Opposition’s misinformation campaign has generated enough negative publicity. Modi govt will be in bigger trouble if Bangladesh’s rumour mills become active.
Has CDS Gen Bipin Rawat overstepped his brief by speaking on ‘de-radicalisation camps’?
Chief of Defence Staff General Bipin Rawat said that India has de-radicalisation camps for the young. He also said that 10-12 years old from Kashmir were being radicalised.
Defence
‘Twitter General’ Asif Ghafoor is no longer Pakistan military’s spokesperson
Asif Ghafoor has been sent to Infantry Division. Major Gen. Babar Iftikhar will be new director general of Inter-Services Public Relations, Pakistan military’s publicity wing.
Under Modi-Shah, BJP is back to being the Bharatiya ‘Baniya’ Party
BJP under Modi-Shah is returning to its protectionist, anti-MNC, technophobic old notions, underlining that strong governments can also be more risk-averse.